Etfs S&p Biotech ETF (ASX: CURE) Share Price and News
Price
$46.91
Movement
0.39 (+0.84%)
as at 18 Mar 3:43pm (20 mins delayed)
52 Week Range
$42.71 - $54.72
1 Year Return
-5.17%
Etfs S&p Biotech ETF Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
$46.91
Day Change
0.39 (+0.84%)
52 Week Range
$42.71 - $54.72
Yesterday's Close
$46.52
Today's Open
$46.87
Days Range
$46.87 - $46.91
Volume
106
Avg. Volume (1 month)
1,219
Turnover
$4,972
as at 18 Mar 3:43pm
Should you invest $1,000 in Light & Wonder right now?
Before you buy Light & Wonder shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys...
See The 5 Stocks *Returns as of 6 March 2025
Etfs S&p Biotech ETF (ASX: CURE)
Latest News
ETFs
2 top ETFs for ASX investors to buy in October
ETFs
2 exciting ETFs named as buys by experts
CURE ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| 14th Mar 2025 2025-03-14T16:28:04 | Half Year Accounts | YesNo | 4:28pm | 19 | 851k |
| 6th Mar 2025 2025-03-06T17:50:37 | Global X Units on Issue - February 2025 | YesNo | 5:50pm | 4 | 235k |
| 13th Feb 2025 2025-02-13T13:40:45 | PDS dated 12 February 2025 | YesNo | 1:40pm | 106 | 925k |
| 6th Feb 2025 2025-02-06T09:36:40 | Global X Units on Issue - January 2025 | YesNo | 9:36am | 4 | 233k |
| 7th Jan 2025 2025-01-07T09:15:05 | Global X Units on Issue - December 2024 | YesNo | 9:15am | 4 | 224k |
| 5th Dec 2024 2024-12-05T09:12:19 | Global X Units on Issue - November 2024 | YesNo | 9:12am | 4 | 243k |
| 4th Nov 2024 2024-11-04T17:25:24 | Global X Units on Issue - October 2024 | YesNo | 5:25pm | 4 | 233k |
| 4th Oct 2024 2024-10-04T17:02:08 | Global X Units on Issue - September 2024 | YesNo | 5:02pm | 4 | 223k |
| 20th Sep 2024 2024-09-20T14:52:58 | Annual Financial Report | YesNo | 2:52pm | 33 | 1.1M |
| 16th Sep 2024 2024-09-16T17:11:43 | PDS dated 16 September 2024 | YesNo | 5:11pm | 106 | 859k |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Oliver Joseph Reynolds | Non-Executive Director | Sep 2023 |
Mr Reynolds has over 20 years of experience in financial services and investment management, with experience leading finance, operations, risk management, compliance, investment, strategy and management teams. Oliver previously worked at BlackRock, and most recently at Coolabah Capital as Chief Financial Officer.
|
| Mr Evan Metcalf | Non-Executive Director | Jun 2022 |
Mr Metcalf has more than 20 years of experience in financial services which includes derivative structuring roles at Credit Suisse and ANZ, as well as a role as a quantitative analyst at Westpac
|
| Young Kim | Non-Executive Director | Jun 2022 |
No Profile Reported in Annual Report.
|
| Mr Namki Kim | Non-Executive Director | Jul 2024 |
--
|
| Mr Emanual Damianakis | Non-Executive Director | Aug 2024 |
--
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| No Top 20 Shareholder Information | 0 | 0.00% |